Two of these, oleandrin (7) and oleandrigenin (9), inhibited the catalytic activity of the Na/K-ATPase and inhibited the expression of fibroblast growth factor 2 (FGF-2) in prostate cancer cells [84,85]. Here, FGF2 is linked to prostate carcinoma.